ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MARIO SIERVO M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,916Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 3593

$582K Total Retail Price of All Prescriptions

Rank: 473 out of 3593

1,195 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 1,195 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 1,195 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 30,384 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$18 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 2,524 2,448 1 1
LISINOPRIL 982 927 2 2
ENALAPRIL MALEATE 896 896 3 38
FOLIC ACID 831 776 4 117
METFORMIN HCL 756 739 5 6
OMEPRAZOLE 742 697 6 5
ALPRAZOLAM 715 645 7 37
RANITIDINE HCL 702 696 8 27
HYDROCHLOROTHIAZIDE 686 684 9 10
GABAPENTIN 661 614 10 16
METOPROLOL SUCCINATE 616 594 11 19
ATENOLOL 556 555 12 11
AMLODIPINE BESYLATE 535 523 13 3
ALENDRONATE SODIUM 534 533 14 22
TEMAZEPAM 524 500 15 56
LORATADINE 499 488 16 129
SYNTHROID 441 394 17 51
FENOFIBRATE 432 412 18 39
ZOLPIDEM TARTRATE 419 414 19 12
FUROSEMIDE 409 407 20 9
GLIPIZIDE 401 388 21 40
SERTRALINE HCL 396 356 22 28
LOSARTAN POTASSIUM 387 384 23 14
VIAGRA 377 377 24 84
RENAL CAPS 374 364 25 112
LEVOXYL 358 340 26 111
IBUPROFEN 352 341 27 43
DONEPEZIL HCL 310 310 28 31
METOPROLOL TARTRATE 263 233 29 8
CARVEDILOL 261 253 30 23
WARFARIN SODIUM 259 259 31 18
FINASTERIDE 254 254 32 79
TAMSULOSIN HCL 249 249 33 33
CLOPIDOGREL 246 237 34 30
HYDROCODONE-ACETAMINOPHEN 246 221 S3 34 7
TRAMADOL HCL 234 232 36 17
DOXAZOSIN MESYLATE 232 232 37 63
PANTOPRAZOLE SODIUM 230 230 38 45
GLYBURIDE 229 219 R 39 55
CLONAZEPAM 206 202 40 164
ESTAZOLAM 205 187 10 41 327
CLOTRIMAZOLE-BETAMETHASONE 199 188 42 94
LANSOPRAZOLE 197 197 43 113
PAROXETINE HCL 197 197 43 62
BUSPIRONE HCL 186 175 45 156
VENTOLIN HFA 183 178 46 80
PLAVIX 183 178 46 42
BENICAR 176 176 48 131
CIALIS 174 162 49 176
AMMONIUM LACTATE 173 161 50 125
ALLOPURINOL 171 171 51 35
SURE COMFORT 169 136 52 159
FLUTICASONE PROPIONATE 153 134 53 32
LIDODERM 146 136 54 78
VOLTAREN 141 132 55 85
PROCTOZONE-HC 140 139 56 209
CETIRIZINE HCL 132 119 57 225
CICLOPIROX 125 99 58 170
AZITHROMYCIN 123 117 59 34
LYRICA 122 120 60 105
PENTOXIFYLLINE 119 119 61 149
LACTULOSE 118 110 62 126
LORAZEPAM 117 108 63 98
DILTIAZEM 24HR ER 116 116 64 177
ADVAIR DISKUS 113 104 65 47
OXYBUTYNIN CHLORIDE 113 113 65 104
CLORAZEPATE DIPOTASSIUM 113 103 65 236
SYMBICORT 112 112 68 160
KLOR-CON 10 108 108 69 114
DICYCLOMINE HCL 108 107 69 190
LISINOPRIL-HYDROCHLOROTHIAZIDE 103 91 71 26
TRIAMTERENE-HCTZ 103 103 71 66
FAMOTIDINE 103 84 71 70
PROMETHAZINE-CODEINE 98 95 R 74 338
KETOCONAZOLE 98 75 74 118
TERAZOSIN HCL 97 97 76 115
GLYBURIDE-METFORMIN HCL 93 93 R 77 95
PRAVASTATIN SODIUM 87 87 78 13
NYSTATIN-TRIAMCINOLONE 87 84 78 203
HYDRALAZINE HCL 86 78 80 107
NAPROXEN 86 86 80 68
BUTALBITAL-ACETAMINOPHEN-CAFFE 85 72 R 82 316
ROBAFEN-DM CLEAR 85 77 82 241
FLUNISOLIDE 84 81 84 261
CHLORTHALIDONE 81 76 85 227
LANTUS 81 72 85 57
VITAMIN D2 81 64 85 124
DIOVAN 80 80 88 46
LANTUS SOLOSTAR 79 53 89 122
OXYBUTYNIN CHLORIDE ER 79 78 89 175
CARBIDOPA-LEVODOPA 78 78 91 135
CIPROFLOXACIN HCL 77 71 92 52
ATORVASTATIN CALCIUM 75 74 93 15
TRADJENTA 73 73 94 335
GALANTAMINE HBR 73 72 94 239
TRIAMCINOLONE ACETONIDE 73 66 94 119
Q-TUSSIN DM 73 64 94 314
NIFEDIPINE ER 70 60 98 75
NAMENDA 70 68 98 50
NEXIUM 69 57 100 36
MUPIROCIN 63 59 101 132
JANUVIA 63 63 101 81
VERAPAMIL ER 62 62 103 99
ATACAND 62 62 103 417
CLOBETASOL PROPIONATE 61 61 105 187
ULTICARE 60 37 106 370
RISPERIDONE 59 54 107 83
SINGULAIR 58 58 108 77
FLUOXETINE HCL 58 36 108 60
METOCLOPRAMIDE HCL 58 58 108 145
PREDNISONE 57 56 111 49
CILOSTAZOL 57 57 111 163
PRILOSEC OTC 54 54 113 334
METHOTREXATE 52 52 114 354
LOPERAMIDE 51 49 115 277
PROPRANOLOL HCL 51 51 115 181
ISOSORBIDE MONONITRATE ER 50 36 117 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 27, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.